US › Healthcare

10X Genomics Inc (TXG)

US · Healthcare · Health Information Services

$47.86+1.81%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$150.8M
Revenue YoY
-2.6%
Net profit
$-13.5M
Profit YoY
+60.8%
EPS
$0.07
EPS estimate
$-0.06
Net margin
-8.9%

EPS came in at 0.07 against a street estimate of -0.06 — a beat of 216.7%.

Key statistics

Market cap
$5.88B
Forward P/E
769.2
P/B
7.34
Book value
$6.31
EPS (TTM)
$-0.17
52-week high
$49.83
52-week low
$11.16
50-day MA
$35.53
200-day MA
$22.99
Beta
2.04

Analyst view

Analysts rate 10X Genomics Inc a buy (7 buy, 9 hold, 0 sell out of 16) with an average price target of $41.54.

Shareholding

Insiders
1.67%
Institutions
111.95%

Largest institutional holders

FundStake
FMR Inc13.97%
ARK Investment Management LLC9.23%
BlackRock Inc7.94%
Vanguard Portfolio Management, LLC5.45%
Quantinno Capital Management LP4.26%
Vanguard Capital Management, LLC4.15%
Sumitomo Mitsui Trust Group Inc4.03%
Amova Asset Management Americas, Inc4.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for 10X Genomics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.